Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Drug Design
Sort By
Newest First
Sign in
1 / 1
1 / 1
Option Agreement
Merck KGaA, Darmstadt, Germany, Enters Into Option Agreement With Quris on Its BioAI Platform for Clinical Safety Prediction
Quris
PR-M02-22-08
Feb 09, 2022
Drug Design
Janssen, Iktos Collaborate on In Silico Drug Design
Emilie Branch
Pharma's Almanac
PAO-M05-19-NI-022
May 21, 2019
Drug Design
Computer-Aided Drug Design Leads to Real Candidate and New Biotech Startup
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M01-19-NI-024
Jan 30, 2019
